Literature DB >> 19111006

c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps.

Yuzo Kodama, David A Brenner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19111006     DOI: 10.1002/hep.22710

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  20 in total

Review 1.  Signal transductions and nonalcoholic fatty liver: a mini-review.

Authors:  Lu Zeng; Wai J Tang; Jin J Yin; Bei J Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

2.  Nuclear Factor High-mobility Group Box1 Mediating the Activation of Toll-like Receptor 4 Signaling in Hepatocytes in the Early Stage of Non-alcoholic Fatty Liver Disease in Mice.

Authors:  L Li; L Chen; L Hu
Journal:  J Clin Exp Hepatol       Date:  2011-09

Review 3.  Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.

Authors:  M Arrese; S J Karpen
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

4.  Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression.

Authors:  Samantha M Yeligar; Keigo Machida; Vijay K Kalra
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

5.  Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease.

Authors:  Hua Yan; Yan-Qiong Gao; Ying Zhang; Huan Wang; Gui-Sheng Liu; Jian-Yuan Lei
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

Review 6.  Insulin signaling and life span.

Authors:  Angelo Avogaro; Saula Vigili de Kreutzenberg; Gian Paolo Fadini
Journal:  Pflugers Arch       Date:  2009-09-13       Impact factor: 3.657

7.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 8.  Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.

Authors:  Alexander J Kovalic; Sanjaya K Satapathy; Naga Chalasani
Journal:  Hepatol Int       Date:  2018-03-29       Impact factor: 6.047

Review 9.  Redox control of liver function in health and disease.

Authors:  Montserrat Marí; Anna Colell; Albert Morales; Claudia von Montfort; Carmen Garcia-Ruiz; José C Fernández-Checa
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

10.  c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.

Authors:  Yuzo Kodama; Tatiana Kisseleva; Keiko Iwaisako; Kouichi Miura; Kojiro Taura; Samuele De Minicis; Christoph H Osterreicher; Bernd Schnabl; Ekihiro Seki; David A Brenner
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.